These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2406205)

  • 21. Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. I. Tumorigenicity and capacity to metastasize.
    Belardelli F; Ferrantini M; Maury C; Santurbano L; Gresser I
    Int J Cancer; 1984 Sep; 34(3):389-95. PubMed ID: 6207117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of mouse interferon alpha/beta on the expression of H-2 (class I) antigens and on the levels of 2'-5' oligoadenylate synthetase activity in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
    Locardi C; Belardelli F; Federico M; Romeo G; Affabris E; Gresser I
    J Biol Regul Homeost Agents; 1987; 1(4):189-94. PubMed ID: 3332546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of endogenous alpha/beta interferon in the selection of virus nonproducer Friend leukemia cells after serial intraperitoneal passages in syngeneic mice.
    Ferrantini M; Belardelli F; Locardi C
    J Virol; 1988 Feb; 62(2):600-5. PubMed ID: 2447292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
    Proietti E; Carpinelli G; Di Vito M; Belardelli F; Gresser I; Podo F
    Cancer Res; 1986 Jun; 46(6):2849-57. PubMed ID: 2421886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of mouse interferon alpha/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
    Gresser I; Maury C; Belardelli F; Maunoury MT; Machover D
    J Natl Cancer Inst; 1988 Mar; 80(2):126-31. PubMed ID: 3422696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of murine interferon-alpha/beta-sensitive and -resistant friend leukemia cells with tumor necrosis factor in combination with murine interferon-alpha/beta or -gamma.
    Van der Heyden J; Fransen L; Fiers W
    J Interferon Res; 1986 Dec; 6(6):633-8. PubMed ID: 3106522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.
    Garaci E; Pica F; Mastino A; Palamara AT; Belardelli F; Favalli C
    J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):7-17. PubMed ID: 8435433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases.
    Gresser I; Maury C; Belardelli F
    Int J Cancer; 1987 Jun; 39(6):789-92. PubMed ID: 2438237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural resistance in mice against Friend leukemia cells. II. Studies with in vivo passaged interferon-sensitive and interferon-resistant cell clones.
    Iorio AM; Neri M; Zei T; Romeo G; Rossi GB; Bonmassar E
    Cell Immunol; 1989 Feb; 118(2):425-34. PubMed ID: 2463101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of in vitro interferon treatment on the rapid clearance of murine leukemia cells in vivo.
    Neri M; Zei T; Rossi GB; Coccia EM; Bonmassar E; Iorio AM
    J Biol Regul Homeost Agents; 1990; 4(2):60-6. PubMed ID: 1701956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural resistance in mice against Friend cells injected intravenously. III. Comparison between in vivo and in vitro passaged interferon-sensitive (745) and interferon-resistant (3Cl8) cell clones.
    Neri M; Zei T; Bonmassar E; Rossi GB; Fiorucci G; Iorio AN
    Br J Cancer; 1989 Jun; 59(6):848-53. PubMed ID: 2736222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.
    Dvorak HF; Gresser I
    J Natl Cancer Inst; 1989 Apr; 81(7):497-502. PubMed ID: 2921774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.
    Ciolli V; Gabriele L; Sestili P; Varano F; Proietti E; Gresser I; Testa U; Montesoro E; Bulgarini D; Mariani G
    J Exp Med; 1991 Feb; 173(2):313-22. PubMed ID: 1671080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic anti-tumor effects of combined IL-1/IFN-alpha/beta therapy in mice injected with metastatic Friend erythroleukemia cells.
    Belardelli F; Gabriele L; Proietti E; Sestili P; Peretti M; Rozera C; Gresser I
    Int J Cancer; 1991 Sep; 49(2):274-8. PubMed ID: 1879971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posttranscriptional regulation of beta interferon expression in erythroid Friend cells treated with gamma interferon.
    Marziali G; Fiorucci G; Coccia EM; Percario Z; Raber J; Battistini A; Rossi GB; Affabris E; Romeo G
    J Virol; 1991 Aug; 65(8):4130-6. PubMed ID: 1649320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposite effects of murine interferons on erythroid differentiation of Friend cells.
    Affabris E; Federico M; Romeo G; Coccia EM; Rossi GB
    Virology; 1988 Nov; 167(1):185-93. PubMed ID: 2460993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction in interferon-alpha/beta-treated hepatocytes of the inhibitor of the multiplication of IFN-alpha/beta-resistant Friend leukemia cells.
    Yasui H; Takikawa O; Oku T; Yoshida R
    J Interferon Res; 1994 Oct; 14(5):245-50. PubMed ID: 7861028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
    Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
    Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant friend leukemia cells. IV. Definition of optimal treatment regimens.
    Gresser I; Belardelli F; Maury C; Tovey MG; Maunoury MT
    Int J Cancer; 1986 Aug; 38(2):251-7. PubMed ID: 2426208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cytokines in GVL (ESb lymphoma) and GVHD after adoptive transfer of allogeneic T lymphocytes in mice.
    Gresser I; Greco G; Santini SM; Woodrow D; Mecchia M; Parlato S; Logozzi M; Venditti M; Maunoury MT; Belardelli F
    J Interferon Cytokine Res; 1998 Sep; 18(9):667-79. PubMed ID: 9781805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.